Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic steroids can slow down or stop the growth of certain skin fungi.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Smoking and drinking worsened hair loss in men with genetic hair loss, while eating and sleeping habits didn't; genetics played a bigger role than environment in hair loss.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Spironolactone may help reduce hair loss in androgenic alopecia.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

PRP shows promise for treating hair loss but needs more research.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Anabolic-androgenic steroids can cause skin issues like acne and oily skin by enlarging oil glands and changing skin oils.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.